Rob Michiels

Rob Michiels has over 40 years of experience in the medical technology space. He most recently served as the CEO of CardiAQ Valve Technologies, a venture funded start-up developing transcatheter mitral valve replacement (TMVR) technology which was acquired by Edwards Lifesciences in 2015. He previously served as COO of CoreValve which was acquired by Medtronic in 2009; and as President and COO of InterVentional Technologies (IVT) which was acquired by Boston Scientific in 2001. He helped drive both companies from cardiovascular start-ups to established market leaders. Rob is currently a director of Aegis Surgical, Atrius, and FEops, all privately held companies developing novel cardiovascular technologies.

Rob is also a founding partner of CONSILIUM, a medical device market research company active in identifying, funding and greenhousing start-up technologies. Rob holds a bachelor’s degree in Economics from Antwerp University in Belgium and an MBA from the Kelley School of Business at Indiana University, Bloomington, Indiana, US.